SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-306571
Filing Date
2017-10-10
Accepted
2017-10-10 09:09:56
Documents
5
Period of Report
2017-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467358d8k.htm 8-K 28241
2 EX-10.1 d467358dex101.htm EX-10.1 63415
3 EX-10.2 d467358dex102.htm EX-10.2 18966
4 EX-99.1 d467358dex991.htm EX-99.1 8737
5 GRAPHIC g467358aanew.jpg GRAPHIC 9973
  Complete submission text file 0001193125-17-306571.txt   134537
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53057 | Film No.: 171128913
SIC: 2834 Pharmaceutical Preparations